Janux Therapeutics JANX
NASDAQ JANX
$17.01 +0.05 (+0.29%)
As of: Oct 2, 2026 · 10:51 AM EDT

Janux Therapeutics (JANX) Depreciation & Amortization (CF) (2020 - 2026)

Updated

Janux Therapeutics (JANX) posted Depreciation & Amortization (CF) of $463,000 for Q2 2026, down 14.4% from $541,000 a year earlier and down 1.3% from the prior quarter.

Analysis

Janux Therapeutics (JANX) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Janux Therapeutics was $1.9 million, down 8.7% year-over-year; for FY2025, it was $2.03 million, down 1.5% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 174.6% (FY2020 to FY2025).
  • In prior years, Janux Therapeutics' Depreciation & Amortization (CF) was $2.06 million in FY2024 (+5.4%), $1.96 million in FY2023 (+132.5%), $841,000 in FY2022 (+644.2%) and $113,000 in FY2021 (+769.2%).
  • The Q2 2026 figure stands as the lowest quarterly Depreciation & Amortization (CF) since Q1 2023.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined in each of the last four quarters, with an average decline of 3.9% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q3 2022, with growth of 822.2%; the weakest was Q2 2026, with a decline of 14.4%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $469,000 (Q1 2026), $468,000 (Q4 2025) and $501,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Janux Therapeutics 1.06 Bn 1.06 Bn - 463,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 463,000.00
Mar 31, 2026 469,000.00
Dec 31, 2025 468,000.00
Sep 30, 2025 501,000.00
Jun 30, 2025 541,000.00
Mar 31, 2025 519,000.00
Dec 31, 2024 512,000.00
Sep 30, 2024 510,000.00
Jun 30, 2024 506,000.00
Mar 31, 2024 532,000.00
Dec 31, 2023 531,000.00
Sep 30, 2023 500,000.00
Jun 30, 2023 471,000.00
Mar 31, 2023 453,000.00
Dec 31, 2022 403,000.00
Sep 30, 2022 249,000.00
Jun 30, 2022 108,000.00
Mar 31, 2022 81,000.00
Dec 31, 2021 64,000.00
Sep 30, 2021 27,000.00
API Access

Janux Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=JANX&period=max&api_key=YOUR_API_KEY